Market closed
Stryker/$SYK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Stryker
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.
Ticker
$SYK
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
53,000
ISIN
US8636671013
Website
Stryker Metrics
BasicAdvanced
$148B
52.44
$7.40
0.94
$3.28
0.87%
Price and volume
Market cap
$148B
Beta
0.94
52-week high
$406.19
52-week low
$314.93
Average daily volume
1.9M
Dividend rate
$3.28
Financial strength
Current ratio
1.642
Quick ratio
0.803
Long term debt to equity
70.698
Total debt to equity
82.924
Dividend payout ratio (TTM)
43.20%
Interest coverage (TTM)
12.85%
Management effectiveness
Return on assets (TTM)
7.45%
Return on equity (TTM)
14.26%
Valuation
Price to earnings (TTM)
52.444
Price to revenue (TTM)
6.374
Price to book
7.09
Price to tangible book (TTM)
-34.56
Price to free cash flow (TTM)
41.371
Dividend yield (TTM)
0.85%
Forward dividend yield
0.87%
Growth
Revenue change (TTM)
10.76%
Earnings per share change (TTM)
-15.51%
3-year revenue growth (CAGR)
10.03%
3-year earnings per share growth (CAGR)
12.06%
3-year dividend per share growth (CAGR)
7.37%
What the Analysts think about Stryker
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Stryker stock.
Stryker Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Stryker Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Stryker News
AllArticlesVideos
Stryker Corporation (SYK) Bank of America Securities 2025 Global Healthcare Conference (Transcript)
Seeking Alpha·12 hours ago
Stryker: Mako Spine And Shoulder Launching Is On Track (Downgrade To Hold)
Seeking Alpha·5 days ago
Final Trades: Rockwell Automation, Alerian MLP, Lockheed Martin and Stryker
CNBC Television·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closed
Upcoming events
Jun30
Stryker
Dividend·Ex-dividend
Jul31
Stryker
Dividend·Payment
$0.84Per share
FAQs
What’s the current market cap for Stryker stock?
Stryker (SYK) has a market cap of $148B as of May 14, 2025.
What is the P/E ratio for Stryker stock?
The price to earnings (P/E) ratio for Stryker (SYK) stock is 52.44 as of May 14, 2025.
Does Stryker stock pay dividends?
Yes, the Stryker (SYK) stock pays dividends to shareholders. As of May 14, 2025, the dividend rate is $3.28 and the yield is 0.87%. Stryker has a payout ratio of 43.2% on a trailing twelve-month basis.
When is the next Stryker dividend payment date?
The next Stryker (SYK) dividend payment is scheduled for July 31, 2025.
What is the beta indicator for Stryker?
Stryker (SYK) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.